Evidence map›Paper›PMID 24958464›Full record

ArticleThe patient2014

Barriers to initiating insulin in type 2 diabetes patients: development of a new patient education tool to address myths, misconceptions and clinical realities.

Meryl Brod, Suzanne Lessard Alolga, Luigi Meneghini

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in The patient, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06652867 (Hypoglycemia Biomarkers to Predict Timing of a Hypoglycemic Event), which is not on this map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06652867 completednot on this mapstarted 2024, after this paper: background citation

Hypoglycemia Biomarkers to Predict Timing of a Hypoglycemic Event

TypeobservationalSponsorRoyal College of Surgeons in Ireland - Medical University of BahrainRan2024 to 2024Enrolled150ConditionsHypoglycemia
3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 80 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Barriers and facilitators to insulin treatment: a phenomenological inquiry.Journal of pharmaceutical policy and practice · 2022
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Efficacy of Semaglutide in a Subcutaneous and an Oral Formulation.Frontiers in endocrinology · 2021 · on this map
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Meryl BrodThe Brod Group, 219 Julia Avenue, Mill Valley, CA, 94941, USA, mbrod@thebrodgroup.net.
Suzanne Lessard Alolga
Luigi Meneghini
Brod Group · USParkland Health & Hospital System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe purpose of this study was to identify patient beliefs as well as clinical realities about insulin that may be barriers to type 2 diabetes patients initiating insulin treatment when recommended by their physician. This information was then used to develop a clinically relevant, cross-culturally valid patient education tool with the goal of providing unbiased, medically informative statements addressing these barriers.

methodsThirteen focus groups were conducted in five countries (Germany, Sweden, The Netherlands, UK, and USA) to collect qualitative data on attitudes about insulin therapy from type 2 diabetes patients aged 18 or older whose physician had recommended initiating insulin treatment in the past 6 months (n = 87). Additionally, a panel of four clinical experts was interviewed to ascertain obstacles they experience in initiating insulin with their patients.

resultsOn the basis of the interview data, the ten questions that asked about the most important barriers were generated. The clinical expert panel then generated clinically accurate and unbiased responses addressing these concerns, and the educational tool "Questions about Starting Insulin: Information on the Myths, Misconceptions and Clinical Realities about Insulin" was drafted. The draft tool was pilot tested in a group of patients and finalized.

conclusionsPatient misconceptions, as well as some clinical realities, about insulin treatment and diabetes can influence the decision to initiate insulin treatment and ultimately impact disease management. The educational tool developed through this study was designed to help patients who are deciding whether or not to initiate insulin therapy as recommended by their physician, and facilitate patient-health-care provider interactions.

Indexed as

Health Knowledge, Attitudes, PracticeAdultAgedAged, 80 and overDecision MakingDiabetes Mellitus, Type 2EuropeFemaleFocus GroupsHumansHypoglycemic AgentsInsulinMaleMiddle AgedPatient Education as TopicPatient ParticipationHypoglycemic AgentsInsulin

Identifiers

PMID24958464
PMCPMC4240906
OpenAlexW1982351242

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.